WO2023079524 - POLYMER-INTERACTION MOLECULE CONJUGATES AND METHODS OF USE
National phase entry:
Publication Number
WO/2023/079524
Publication Date
11.05.2023
International Application No.
PCT/IB2022/060693
International Filing Date
07.11.2022
Title **
[English]
POLYMER-INTERACTION MOLECULE CONJUGATES AND METHODS OF USE
[French]
CONJUGUÉS POLYMÈRE-MOLÉCULES D'INTERACTION ET PROCÉDÉS D'UTILISATION
Applicants **
LIFE TECHNOLOGIES AS
Inventors
OOI, Huey Wen
LUNDBERG, Pontus
BOESCHEN, Maxi-Lu
ALMAASBAK, Hilde
HERENG, Tuva Holt
STAV-NORAAS, Tor-Espen
LANDSVERK, Ole
FONNUM, Geir
Priority Data
63/276,739
08.11.2021
US
63/382,416
04.11.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4420 | |
| EPO | Filing, Examination, Granting | 52999 | |
| Japan | Filing, Examination, Granting | 3851 | |
| South Korea | Filing, Examination, Granting | 5389 | |
| USA | Filing, Examination, Granting | 16790 |
Total:
83,449
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to polymer-interaction molecule (e.g., antibodies) conjugates and uses of such conjugates for delivery of interaction molecules to cells. The invention also relates uses polymer-interaction molecule (e.g., antibodies) conjugates for eliciting cellular responses (e.g., induction of cell proliferation).[French]
L'invention concerne des conjugués polymère-molécules d'interaction (par exemple, des anticorps) et des utilisations de ces conjugués permettant l'apport de molécules d'interaction à des cellules. L'invention concerne également des conjugués polymère-molécules d'interaction (par exemple, des anticorps) pour déclencher des réponses cellulaires (par exemple, l'induction d'une prolifération cellulaire).